NCT00584831

Brief Summary

The relative performance of a new toric soft contact lens against toric contact lenses currently available in market, specifically for visual acuity and lens orientation. The study will be conducted in a staged approach (2 stages).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2007

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2007

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 20, 2007

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 2, 2008

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2008

Completed
3.8 years until next milestone

Results Posted

Study results publicly available

November 1, 2011

Completed
Last Updated

May 21, 2015

Status Verified

May 1, 2015

Enrollment Period

4 months

First QC Date

December 20, 2007

Results QC Date

September 24, 2009

Last Update Submit

May 5, 2015

Conditions

Keywords

astigmatismvisual acuityorientationcontact lenses

Outcome Measures

Primary Outcomes (4)

  • Visual Acuity After Infero-temporal Version Movement.

    logarithm of the minimum angle of resolution (logMar) ideal is 0.0 and represents 20/20 Snellen acuity. logMar values \> 0.00 indicate vision poorer than the ideal and values \<0.00 indicate vision greater than the ideal.

    10 minutes after insertion

  • Visual Acuity After Infero-nasal Version Movement.

    logarithm of the minimum angle of resolution (logMar) ideal is 0.0 and represents 20/20 Snellen acuity. logMar values \> 0.00 indicate vision poorer than the ideal and values \<0.00 indicate vision greater than the ideal.

    10 minutes after lens insertion

  • Visual Acuity After Superior-temporal Version Movement

    logarithm of the minimum angle of resolution (logMar) ideal is 0.0 and represents 20/20 Snellen acuity. logMar values \> 0.00 indicate vision poorer than the ideal and values \<0.00 indicate vision greater than the ideal.

    10 minutes after lens insertion

  • Visual Acuity After Superior-nasal Version Movement.

    logarithm of the minimum angle of resolution (logMar) ideal is 0.0 and represents 20/20 Snellen acuity. logMar values \> 0.00 indicate vision poorer than the ideal and values \<0.00 indicate vision greater than the ideal.

    10 minutes after lens insertion

Study Arms (19)

Group 2 LSBO

ACTIVE COMPARATOR

contact lenses worn in this order: lotrafilcon B toric, senofilcon A toric, balafilcon A toric, omafilcon A toric

Device: senofilcon ADevice: balafilcon ADevice: omafilcon ADevice: lotrafilcon B

Group 3 LOSB

ACTIVE COMPARATOR

contact lenses worn in this order: lotrafilcon B toric, omafilcon A toric, senofilcon A toric, balafilcon A toric

Device: senofilcon ADevice: balafilcon ADevice: omafilcon ADevice: lotrafilcon B

Group 4 LBSO

ACTIVE COMPARATOR

contact lenses worn in this order: lotrafilcon B toric, balafilcon A toric, senofilcon A toric, omafilcon A toric

Device: senofilcon ADevice: balafilcon ADevice: omafilcon ADevice: lotrafilcon B

Group 5 LBOS

ACTIVE COMPARATOR

contact lenses worn in this order: lotrafilcon B toric, balafilcon A toric, omafilcon A toric, senofilcon A

Device: senofilcon ADevice: balafilcon ADevice: omafilcon ADevice: lotrafilcon B

Group 6 SLOB

ACTIVE COMPARATOR

contact lenses worn in this order: senofilcon A toric, lotrafilcon B toric, omafilcon A toric, balafilcon A toric

Device: senofilcon ADevice: balafilcon ADevice: omafilcon ADevice: lotrafilcon B

Group 7 SLBO

ACTIVE COMPARATOR

contact lenses worn in this order: senofilcon A toric, lotrafilcon B toric, balafilcon A toric, omafilcon A toric

Device: senofilcon ADevice: balafilcon ADevice: omafilcon ADevice: lotrafilcon B

Group 8 SOLB

ACTIVE COMPARATOR

contact lenses worn in this order: senofilcon A toric, omafilcon A toric, lotrafilcon B toric, balafilcon A toric

Device: senofilcon ADevice: balafilcon ADevice: omafilcon ADevice: lotrafilcon B

Group 9 SBLO

ACTIVE COMPARATOR

contact lenses worn in this order: senofilcon A toric, balafilcon A toric, lotrafilcon B toric, omafilcon A toric

Device: senofilcon ADevice: balafilcon ADevice: omafilcon ADevice: lotrafilcon B

Group 10 SBOL

ACTIVE COMPARATOR

contact lenses worn in this order: senofilcon A toric, balafilcon A toric, omafilcon A toric, lotrafilcon B toric

Device: senofilcon ADevice: balafilcon ADevice: omafilcon ADevice: lotrafilcon B

Group 11 OSLB

ACTIVE COMPARATOR

contact lenses worn in this order: omafilcon A toric, senofilcon A toric, lotrafilcon B toric, balafilcon A toric

Device: senofilcon ADevice: balafilcon ADevice: omafilcon ADevice: lotrafilcon B

Group 12 OSBL

ACTIVE COMPARATOR

contact lenses worn in this order: omafilcon A toric, senofilcon A toric, balafilcon A toric, lotrafilcon B toric

Device: senofilcon ADevice: balafilcon ADevice: omafilcon ADevice: lotrafilcon B

Group 13 OBLS

ACTIVE COMPARATOR

contact lenses worn in this order: omafilcon A toric, balafilcon A toric, lotrafilcon B toric, senofilcon A toric

Device: senofilcon ADevice: balafilcon ADevice: omafilcon ADevice: lotrafilcon B

Group 14 OBSL

ACTIVE COMPARATOR

contact lenses worn in this order: omafilcon A toric, balafilcon A toric, senofilcon A toric, lotrafilcon B toric

Device: senofilcon ADevice: balafilcon ADevice: omafilcon ADevice: lotrafilcon B

Group 15 BLSO

ACTIVE COMPARATOR

contact lenses worn in this order: balafilcon A toric, lotrafilcon B toric, senofilcon A toric, omafilcon A toric

Device: senofilcon ADevice: balafilcon ADevice: omafilcon ADevice: lotrafilcon B

Group 16 BLOS

ACTIVE COMPARATOR

contact lenses worn in this order: balafilcon A toric, lotrafilcon B toric, omafilcon A toric, senofilcon A toric

Device: senofilcon ADevice: balafilcon ADevice: omafilcon ADevice: lotrafilcon B

Group 17 BSOL

ACTIVE COMPARATOR

contact lenses worn in this order: balafilcon A toric, senofilcon A toric, omafilcon A toric, lotrafilcon B toric

Device: senofilcon ADevice: balafilcon ADevice: omafilcon ADevice: lotrafilcon B

Group 18 BOLS

ACTIVE COMPARATOR

contact lenses worn in this order: balafilcon A toric, omafilcon A toric, lotrafilcon B toric, senofilcon A toric

Device: senofilcon ADevice: balafilcon ADevice: omafilcon ADevice: lotrafilcon B

Group 19 BOSL

ACTIVE COMPARATOR

contact lenses worn in this order: balafilcon A toric, omafilcon A toric, senofilcon A toric, lotrafilcon B toric

Device: senofilcon ADevice: balafilcon ADevice: omafilcon ADevice: lotrafilcon B

Group 1 LSOB

ACTIVE COMPARATOR

contact lenses worn in this order: lotrafilcon B toric/senofilcon A toric/omafilconA toric/balafilcon A toric

Device: senofilcon ADevice: balafilcon ADevice: omafilcon ADevice: lotrafilcon B

Interventions

toric contact lens

Group 1 LSOBGroup 10 SBOLGroup 11 OSLBGroup 12 OSBLGroup 13 OBLSGroup 14 OBSLGroup 15 BLSOGroup 16 BLOSGroup 17 BSOLGroup 18 BOLSGroup 19 BOSLGroup 2 LSBOGroup 3 LOSBGroup 4 LBSOGroup 5 LBOSGroup 6 SLOBGroup 7 SLBOGroup 8 SOLBGroup 9 SBLO

toric contact lens

Group 1 LSOBGroup 10 SBOLGroup 11 OSLBGroup 12 OSBLGroup 13 OBLSGroup 14 OBSLGroup 15 BLSOGroup 16 BLOSGroup 17 BSOLGroup 18 BOLSGroup 19 BOSLGroup 2 LSBOGroup 3 LOSBGroup 4 LBSOGroup 5 LBOSGroup 6 SLOBGroup 7 SLBOGroup 8 SOLBGroup 9 SBLO

toric contact lens

Group 1 LSOBGroup 10 SBOLGroup 11 OSLBGroup 12 OSBLGroup 13 OBLSGroup 14 OBSLGroup 15 BLSOGroup 16 BLOSGroup 17 BSOLGroup 18 BOLSGroup 19 BOSLGroup 2 LSBOGroup 3 LOSBGroup 4 LBSOGroup 5 LBOSGroup 6 SLOBGroup 7 SLBOGroup 8 SOLBGroup 9 SBLO

toric contact lens

Group 1 LSOBGroup 10 SBOLGroup 11 OSLBGroup 12 OSBLGroup 13 OBLSGroup 14 OBSLGroup 15 BLSOGroup 16 BLOSGroup 17 BSOLGroup 18 BOLSGroup 19 BOSLGroup 2 LSBOGroup 3 LOSBGroup 4 LBSOGroup 5 LBOSGroup 6 SLOBGroup 7 SLBOGroup 8 SOLBGroup 9 SBLO

Eligibility Criteria

Age18 Years - 39 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • They are aged between 18-39 years.
  • They understand their rights as a research subject and are willing to sign a Statement of Informed Consent.
  • They are willing and able to follow the protocol.
  • They can attain at least 6/9 in each eye with their spectacle refraction.
  • They have successfully worn contact lenses within six months of starting the study.
  • They can be fitted with toric soft contact lenses to match the available power range.

You may not qualify if:

  • They have an ocular disorder which would normally contra-indicate contact lens wear.
  • They have a systemic disorder which would normally contra-indicate contact lens wear.
  • They are using any topical medication such as eye drops or ointment.
  • They are aphakic.
  • They have had corneal refractive surgery.
  • They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
  • They are pregnant or lactating.
  • They have grade 2 or greater of any of the following ocular surface signs: corneal oedema, corneal vascularisation, corneal staining, tarsal conjunctival changes or any other abnormality which would normally contraindicate contact lens wear.
  • They have taken part in any other clinical trial or research, within two weeks prior to starting this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eurolens Research, The University of Manchester Dpt. of Optometry & Neuroscience

Manchester, M60 1QD, United Kingdom

Location

MeSH Terms

Conditions

AstigmatismOrientation, Spatial

Condition Hierarchy (Ancestors)

Refractive ErrorsEye DiseasesSpatial BehaviorBehavior

Results Point of Contact

Title
Kurt Moody, OD, FAAO
Organization
Vistakon

Study Officials

  • Philip Morgan, PhD MCOptom

    Eurolens Research, The University of Manchester Dpt. of Optometry and Neuroscience

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2007

First Posted

January 2, 2008

Study Start

October 1, 2007

Primary Completion

February 1, 2008

Study Completion

February 1, 2008

Last Updated

May 21, 2015

Results First Posted

November 1, 2011

Record last verified: 2015-05

Locations